Listen

Description

Have you done Corrective and Preventive Actions (CAPA) on your CAPA process? If not, you need to seriously consider doing so because CAPA is the #1 reason why companies get 483 observations year after year.

In this episode of the Global Medical Device Podcast, Jon Speer talks to Mike Drues of Vascular Sciences about whether your medical device company’s CAPA process needs a CAPA. Why are medical devices companies continuing to struggle with CAPAs?

Some of the highlights of this episode include:

Memorable quotes from this episode:

“A CAPA is an opportunity to really do a deep dive investigation to determine, is there a systemic issue that is influencing that process that you are following?” Jon Speer

 “People don’t focus on the common sensical understanding.” Mike Drues

 “Unless regulation makes sense, I don’t care what the regulation is, unless it makes sense, it is not good regulation.” Mike Drues

 “Part of going through the CAPA procedure is to identify the root cause of the problem.” Mike Drues

 “Only 3-5% of adverse events of medical devices are actually reported to the manufacturer or to the FDA.” Mike Drues

Links:

FDA - Corrective and Preventive Actions (CAPA)

FDA - Form 483 Observations and Warning Letters

FDA - Medical Device Overview

International Medical Device Regulators Forum (IMDRF)

ISO 13485 CAPA

21 CFR Part 820

Mike Drues on LinkedIn

Greenlight Guru Academy